NEW YORK, Nov. 26, 2014 /PRNewswire/ -- Faruqi &
Faruqi, LLP, a leading national securities law firm, reminds
investors in Albany Molecular Research, Inc. ("Albany" or the "Company") (NASDAQ: AMRI) of
the January 12, 2015 deadline to seek
the role of lead plaintiff in a federal securities class action
lawsuit filed against Albany and
certain officers of the Company.
A complaint has been filed in the United States District Court
for the Eastern District of New
York on behalf of all persons who purchased Albany common stock between August 5, 2014 and November 5, 2014 (the "Class Period").
The complaint alleges that the Company and its executives
violated federal securities laws with respect to its disclosures
concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period,
Albany issued false and misleading
statements concerning operations at its OsoBio facility.
On November 5, 2014, the Company
announced that a business interruption event at its OsoBio facility
in late July resulted in weak third quarter 2014 results and that
the facility would not be back online until mid-November.
Following this news, the price of Albany's stock declined by $6.08 per share, or over 26%, to close on
November 5, 2014 at $16.59 per share.
Request more information now by clicking here:
www.faruqilaw.com/AMRI. There is no cost or obligation to
you.
Take Action
If you invested in Albany
common stock, bonds or options between August 5, 2014 and November 5, 2014 and would like to discuss your
legal rights, visit www.faruqilaw.com/AMRI. You can also contact us
by calling Richard Gonnello toll
free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to
rgonnello@faruqilaw.com. Faruqi & Faruqi, LLP also encourages
anyone with information regarding Albany's conduct to contact the firm,
including whistleblowers, former employees, shareholders and
others.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The
firm is focused on providing exemplary legal services in complex
litigation in the areas of securities, shareholder, antitrust and
consumer litigation, throughout all phases of litigation. The
firm has an experienced trial team which has achieved significant
victories on behalf of the firm's clients. To keep track of the
latest securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with
respect to any future matter. We welcome the opportunity to discuss
your particular case. All communications will be treated in a
confidential manner.
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello,
Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Logo -
http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-albany-molecular-research-inc-amri-to-contact-the-firm-300001782.html
SOURCE Faruqi & Faruqi, LLP